Sectoral Asset Management Inc Evelo Biosciences, Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$3.21 - $7.06 $2.03 Million - $4.47 Million	-632,582 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$3.81 - $7.45 $381,000 - $745,000	-100,000 Reduced 13.65%	632,582 $2.57 Million
Q3 2019 Nov 14, 2019	BUY	$5.45 - $8.8 $344,440 - $556,160	63,200 Added 9.44%	732,582 $4.47 Million
Q2 2019 Aug 14, 2019	BUY	$6.52 - $9.42 $119,348 - $172,433	18,305 Added 2.81%	669,382 $6.01 Million
Q1 2019 May 14, 2019	BUY	$7.5 - $15.31 $1.83 Million - $3.73 Million	243,906 Added 59.9%	651,077 $5.21 Million
Q3 2018 Nov 14, 2018	SELL	$11.93 - $14.76 $361,824 - $447,656	-30,329 Reduced 6.93%	407,171 $4.96 Million
Q2 2018 Aug 13, 2018	BUY	$11.39 - $16.26 $4.98 Million - $7.11 Million	437,500 New	437,500 $5.16 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.